Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity

被引：0
|
作者：
Chun-jun Li
Jing Li
Qiu-mei Zhang
Lin Lv
Rui Chen
Chun-feng Lv
Pei Yu
De-min Yu
机构：
[1] Metabolic Disease Hospital & Tianjin Institute of Endocrinology,2011 Collaborative Innovation Center of Tianjin for Medical Epigenetics, Key Laboratory of Hormone and Development (Ministry of Health)
[2] Tianjin Medical University,undefined
来源：
Cardiovascular Diabetology | / 11卷
关键词：
Liraglutide; Abdominal obesity; Insulin therapy; Weight reduction;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity
    Li, Chun-jun
    Li, Jing
    Zhang, Qiu-mei
    Lv, Lin
    Chen, Rui
    Lv, Chun-feng
    Yu, Pei
    Yu, De-min
    CARDIOVASCULAR DIABETOLOGY, 2012, 11
  • [2] Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study
    Hong, E. S.
    Khang, A. R.
    Yoon, J. W.
    Kang, S. M.
    Choi, S. H.
    Park, K. S.
    Jang, H. C.
    Shin, H.
    Walford, G. A.
    Lim, S.
    DIABETES OBESITY & METABOLISM, 2012, 14 (09): : 795 - 802
  • [3] A comparison of adding liraglutide versus a single daily dose of insulin aspart to insulin degludec in subjects with type 2 diabetes (BEGIN: VICTOZA ADD-ON)
    Mathieu, C.
    Rodbard, H. W.
    Cariou, B.
    Handelsman, Y.
    Philis-Tsimikas, A.
    Francisco, A. M. Ocampo
    Rana, A.
    Zinman, B.
    DIABETES OBESITY & METABOLISM, 2014, 16 (07): : 636 - 644
  • [4] Efficacy and Safety Comparison of Add-on Therapy with Liraglutide, Saxagliptin and Vildagliptin, All in Combination with Current Conventional Oral Hypoglycemic Agents Therapy in Poorly Controlled Chinese Type 2 Diabetes
    Li, C. -J.
    Yu, Q.
    Yu, P.
    Zhang, Q. -M.
    Ding, M.
    Liu, X. -J.
    Yu, D. -M.
    EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES, 2014, 122 (08) : 469 - 476
  • [5] Efficacy and Safety of Linagliptin as Add-On Therapy to Basal Insulin in Patients With Type 2 Diabetes
    Yki-Jarvinen, Hannele
    Duran-Garcia, Santiago
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Thiemann, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2012, 61 : A255 - A255
  • [6] Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin
    Barnett, Anthony H.
    Charbonnel, Bernard
    Donovan, Mark
    Fleming, Douglas
    Chen, Roland
    CURRENT MEDICAL RESEARCH AND OPINION, 2012, 28 (04) : 513 - 523
  • [7] Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy
    Kadowaki T.
    Tajima N.
    Odawara M.
    Minamide T.
    Kawashima M.
    Yanagida D.
    Okamoto T.
    Arjona Ferreira J.C.
    Diabetology International, 2013, 4 (3) : 160 - 172
  • [8] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in patients with type 2 diabetes
    Lee, J.
    Duran-Garcia, S.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S355 - S355
  • [9] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [10] Twelve Weeks Treatment with Liraglutide as Add-on to Insulin in Normal-Weight Poorly Controlled Patients with Type 1 Diabetes
    Frandsen, Christian S.
    Dejgaard, Thomas F.
    Andersen, Henrik Ullits
    Holst, Jens J.
    Thorsteinsson, Birger
    Madsbad, Sten
    DIABETES, 2015, 64 : A74 - A74
12345